- Home
- COVID-19
- Services
- Products
- Research Areas
- Company
- Resources
- Ordering
Ac2-26 TFA, an active N-terminal peptide of annexin A1 (AnxA1), attenuates ischemia-reperfusion-induced acute lung injury. Ac2-26 also decreases AnxA1 protein expression, inhibits the activation of NF-κB and MAPK pathways in the injured lung tissue.
| CAT# | R1145 |
| M.F/Formula | C₁₄₃H₂₁₁F₃N₃₂O₄₆S |
| M.W/Mr. | 3203.45 |
| Sequence | One Letter Code: Ala-Met-Val-Ser-Glu-Phe-Leu-Lys-Gln-Ala-Trp-Phe-Ile-Glu-Asn-Glu-Glu-Gln-Glu-Tyr-Val-Gln-Thr-Val-Lys three Letter Code: AMVSEFLKQAWFIENEEQEYVQTVK |
| CAT# | Product Name | M.W | Molecular Formula | Inquiry |
|---|---|---|---|---|
| R1218 | Asp-Asp-Asp-Asp-Asp | Inquiry | ||
| R1842 | Crotamine | Inquiry | ||
| R0997 | Cetrorelix Acetate | Inquiry | ||
| HB00039 | Z-AEVD-FMK | Inquiry | ||
| R1273 | Cecropin A | Inquiry |
* Please kindly note that our products and services can only be used to support research purposes (Not for clinical use).
